Franklin Street Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,232
| Closed | -$31K | – | 159 |
|
|
2023
Q1 | $31K | Hold |
4,232
| – | – | ﹤0.01% | 144 |
|
|
2022
Q4 | $48K | Hold |
4,232
| – | – | ﹤0.01% | 142 |
|
|
2022
Q3 | $56K | Hold |
4,232
| – | – | 0.01% | 138 |
|
|
2022
Q2 | $53K | Hold |
4,232
| – | – | 0.01% | 147 |
|
|
2022
Q1 | $243K | Hold |
4,232
| – | – | 0.02% | 138 |
|
|
2021
Q4 | $503K | Buy |
4,232
+88
| +2% | +$10.5K | 0.04% | 110 |
|
|
2021
Q3 | $824K | Hold |
4,144
| – | – | 0.07% | 90 |
|
|
2021
Q2 | $721K | Hold |
4,144
| – | – | 0.06% | 92 |
|
|
2021
Q1 | $821K | Buy |
4,144
+1,204
| +41% | +$239K | 0.08% | 87 |
|
|
2020
Q4 | $578K | Hold |
2,940
| – | – | 0.06% | 99 |
|
|
2020
Q3 | $521K | Buy |
2,940
+940
| +47% | +$167K | 0.06% | 95 |
|
|
2020
Q2 | $463K | Buy |
2,000
+600
| +43% | +$139K | 0.06% | 96 |
|
|
2020
Q1 | $163K | Buy |
1,400
+200
| +17% | +$23.3K | 0.02% | 127 |
|
|
2019
Q4 | $229K | Hold |
1,200
| – | – | 0.03% | 139 |
|
|
2019
Q3 | $231K | Hold |
1,200
| – | – | 0.03% | 139 |
|
|
2019
Q2 | $206K | Hold |
1,200
| – | – | 0.03% | 150 |
|
|
2019
Q1 | $242K | Buy |
1,200
+400
| +50% | +$80.7K | 0.03% | 131 |
|
|
2018
Q4 | $150K | Buy |
+800
| New | +$150K | 0.02% | 137 |
|